<SEC-DOCUMENT>0001851416-25-000004-index.html : 20250121
<SEC-HEADER>0001851416-25-000004.hdr.sgml : 20250121
<ACCEPTANCE-DATETIME>20250121130108
ACCESSION NUMBER:		0001851416-25-000004
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250121

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			China SXT Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001723980
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			D8
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-90926
		FILM NUMBER:		25541557

	BUSINESS ADDRESS:	
		STREET 1:		178 TAIDONG ROAD NORTH
		CITY:			TAIZHOU
		STATE:			F4
		ZIP:			225300
		BUSINESS PHONE:		8652386298290

	MAIL ADDRESS:	
		STREET 1:		178 TAIDONG ROAD NORTH
		CITY:			TAIZHOU
		STATE:			F4
		ZIP:			225300

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Streeterville Capital LLC
		CENTRAL INDEX KEY:			0001851416
		ORGANIZATION NAME:           	
		IRS NUMBER:				852954598
		STATE OF INCORPORATION:			UT
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		303 E WACKER DRIVE
		STREET 2:		SUITE 1040
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60601
		BUSINESS PHONE:		312-297-7000

	MAIL ADDRESS:	
		STREET 1:		303 E WACKER DRIVE
		STREET 2:		SUITE 1040
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60601

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Streetervile Capital LLC
		DATE OF NAME CHANGE:	20210315
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
Document 1 - file: primary_doc.html

Document 1 - RAW XML: primary_doc.xml

</DOCUMENT>
</SEC-DOCUMENT>